FDA Inspection 1210115 — Baylor University Medical Center Transfusion Services
The FDA completed an inspection of Baylor University Medical Center Transfusion Services on June 13, 2023 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 13, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)